COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

Why COVID-19 is, in fact, a microvascular disease—and what that means for clinicians

The combination of inflammation and thrombosis is crucial, suggesting that endothelial dysfunction could be at the heart of this complex infection.

Thumbnail

How a hard-hit medical center cleaned COVID’s proverbial clock

During a 12-week peak in the COVID-19 crisis, an 800-bed academic hospital in a frenetic American city admitted more than 9,000 inpatients—including almost 700 with COVID—while letting only two infections sneak in unchecked. 

Thumbnail

Long-term heart damage from COVID-19 may ‘improve with time,’ new study suggests

Researchers focused on long-term heart and lung damage among recovered COVID-19 patients, turning to lung function tests, CT imaging and echocardiograms. 

Thumbnail

Penn State doctor clarifies surprising comments about myocarditis and COVID-19

Myocarditis continues to make headlines in the world of college athletics. 

Thumbnail

NIH announces $129M to expand rapid COVID-19 testing technologies

In total, nine organizations will receive funding as part of the institute's Rapid Acceleration of Diagnostics initiative or RADx.

Thumbnail

New discovery might explain why blood clots are so common among COVID-19 patients

The team's analysis also examines why blood-thinning medications aren't effectively preventing the clots. 

American College of Cardiology pushes back ACC.21 due to COVID-related uncertainty

ACC.21 will now take place May 15-17, 2021, in Atlanta.

Confirmed: Key heart medications safe to use for COVID-19 patients

The BRACE CORONA trial focused on the safety of taking angiotensin-converting enzyme inhibitors and angiotensin receptor blockers when hospitalized with COVID-19.